Francesco Ricchetti

Ospedale Sacro Cuore Don Calabria

Papers

1

Total Citations

45

H-Index

1

About

Francesco Ricchetti is a leading figure in the field of radiation oncology, with a particular focus on advanced techniques for prostate cancer treatment. His research centers on the optimization of hypofractionated radiotherapy, volumetric modulated arc therapy (VMAT), and daily image-guided radiotherapy (IGRT) to improve treatment precision and patient outcomes. Ricchetti’s major contribution is demonstrating the feasibility and safety of moderate hypofractionation in the postprostatectomy setting, a critical area where standard fractionation has long been the norm. His seminal 2017 work, cited 45 times, provided a pivotal mono-institutional report showing that combining VMAT with daily IGRT yields excellent acute toxicity profiles, paving the way for shorter, more convenient treatment regimens without compromising safety. This study has influenced clinical protocols and sparked further investigation into hypofractionated approaches. Ricchetti’s work is notable for its rigorous methodology and direct clinical applicability, making him a respected voice in the ongoing effort to refine radiotherapy delivery. His research continues to shape best practices in genitourinary oncology, offering tangible benefits for patients and clinicians alike.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
45 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Ospedale Sacro Cuore Don Calabria

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago